Clinical trial
A Trial to Investigate the Relative Bioavailability, Relative Biopotency and Food Effect of SCD0503 (Oral Insulin) in Comparison to Subcutaneous Regular Human Insulin Under Euglycaemic Clamp Conditions and After Food Intake in People With Type I Diabetes
NCT07634770 is registered in ClinicalTrials.gov with Sam Chun Dang Pharm. Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial to Investigate the Relative Bioavailability, Relative Biopotency and Food Effect of SCD0503 (Oral Insulin) in Comparison to Subcutaneous Regular Human Insulin Under Euglycaemic Clamp Conditions and After Food Intake in People With Type I Diabetes
- Lead sponsor
- Sam Chun Dang Pharm. Co. Ltd.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 29, 2026
- Completion date
- October 31, 2026
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.